Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.06. | Alpha Tau files to sell 3.46M ordinary shares by selling shareholders | 1 | Seeking Alpha | ||
17.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
28.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
19.05. | Alpha Tau Medical GAAP EPS of -$0.11 | 1 | Seeking Alpha | ||
ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
19.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update | 156 | GlobeNewswire (Europe) | - Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive... ► Artikel lesen | |
19.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
12.05. | Alpha Tau Medical ernennt neues Vorstandsmitglied | 5 | Investing.com Deutsch | ||
12.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors | 1 | GlobeNewswire (USA) | ||
06.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
28.04. | Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical | 6 | Seeking Alpha | ||
28.04. | Oramed investiert 36,9 Millionen US-Dollar in Alpha Tau Krebstherapie | 25 | Investing.com Deutsch | ||
28.04. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
28.04. | Alpha Tau Medical Ltd.: Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals | 2 | GlobeNewswire (USA) | ||
28.04. | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | 359 | PR Newswire | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
02.04. | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma | 254 | GlobeNewswire (Europe) | JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA... ► Artikel lesen | |
02.04. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
12.03. | Alpha Tau Medical Ltd. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
12.03. | Alpha Tau Medical Ltd.: Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update | 708 | GlobeNewswire (Europe) | - Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive... ► Artikel lesen | |
12.03. | Alpha Tau Medical Ltd. - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
12.03. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 49,490 | +1,98 % | Ohne Wolfram kein Hightech - dieser Flaschenhals bringt Rendite: Almonty, Siemens Healthineers, Intel | Wolfram gilt aufgrund seiner Härte und Hitzebeständigkeit als Rüstungsmetall. Doch es ist auch einer der unsichtbaren Motoren der Hightech-Industrie. Wir erklären anhand von Beispielen aus der Medizintechnik... ► Artikel lesen | |
FRESENIUS | 42,460 | +0,38 % | Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars | DJ Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars
DOW JONES--Fresenius hat nach eigener Aussage die Zulassung der EU-Kommission für zwei Biosimilars in Europa erhalten.
Wie Fresenius... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 44,980 | -0,62 % | Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil | DJ Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil
DOW JONES--Fitch Ratings hat die Langfrist-Ratings von Fresenius Medical Care (FMC) mit "BBB-" bestätigt. Der Rating-Ausblick... ► Artikel lesen | |
GERRESHEIMER | 44,840 | -2,73 % | Evotec, Gerresheimer, Hugo Boss, Puma, Renk Group, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
GENEDX | 103,57 | +12,99 % | GeneDx stock price target raised to $125 from $100 at BTIG on strong Q2 | ||
CARL ZEISS MEDITEC | 50,05 | -2,15 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
HIMS & HERS HEALTH | 57,28 | +9,65 % | Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears | ||
UNITEDHEALTH | 233,45 | +3,14 % | UnitedHealth: Justizministerium ermittelt - Aktie unter Druck | Schlechte Nachrichten für die Aktionäre von UnitedHealth: Der US-Gesundheitskonzern hat bestätigt, dass das Justizministerium (DOJ) sowohl straf- als auch zivilrechtliche Ermittlungen gegen das Unternehmen... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 13,045 | 0,00 % | Insights into Alignment Healthcare's Upcoming Earnings | ||
BRIGHTSPRING HEALTH SERVICES | 21,320 | +6,07 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,37 | -4,61 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen | |
BIONEXUS GENE LAB | 7,250 | 0,00 % | BioNexus Gene Lab Corp - 8-K, Current Report | ||
ATRICURE | 35,110 | 0,00 % | Starke Q2-Ergebnisse: Needham erhöht Kursziel für AtriCure auf 45 USD/n | ||
INCANNEX HEALTHCARE | 0,842 | -0,17 % | Pre-market Movers: Linkhome, Eightco Holdings, Incannex Healthcare, Coursera, NextCure | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Linkhome Holdings Inc. (LHAI) is up over 120% at $12.40.
Eightco... ► Artikel lesen | |
LIFEMD | 10,090 | 0,00 % | LifeMD, Inc.: LifeMD to Report Second Quarter 2025 Financial Results on August 5 |